Menu

Keryx Biopharmaceuticals, Inc. KERX

Full chart Compare
Set alert

Price alert · KERX

All alert types
3.36 0.00 (+0.00%)

At closeJun 28, 2019, 6:07 PM EDT

3.36 Day range 3.36
2.47 52-week range 5.98

Revenue & Expenses

Income Tax Benefit → Expenses: $235.00KExpenses → Selling, General & Admin: $99.62MExpenses → Research & Development: $37.68MExpenses → Other Operating Expenses: $3.08MExpenses → Other Expenses: $61.98MGross Profit → Expenses: $38.69MRevenue → Gross Profit: $38.69MRevenue → Cost of Revenue: $21.95MNet Loss → Expenses: $163.44MIncome Tax Benefit$235.00KGross Profit$38.69MNet Loss$163.44MCost of Revenue$21.95MExpenses$202.36MSelling, General & Admin$99.62MResearch & Development$37.68MOther Operating Expenses$3.08MOther Expenses$61.98MRevenue$60.64M

Latest period ending Dec 31, 2017 · select a line to chart its full history

KERX annual income statement
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
60.64M31.98M13.68M10.82M7.00M
38.69M-5.82M9.16M10.82M7.00M
-101.69M-122.76M-111.07M-111.23M-47.08M
-163.44M-161.09M-123.14M-111.52M-46.73M
-1.43-1.52-1.19-1.23-0.58
KERX annual balance sheet
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
93.53M111.81M200.29M74.28M55.70M
158.87M141.43M258.69M103.63M60.77M
172.97M149.72M171.75M30.14M15.37M
125.00M125.00M90.77M00
-14.10M-8.30M86.93M73.48M45.40M
KERX annual cash flow
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
-93.49M-86.60M-127.46M-81.00M-34.32M
-1.26M-2.07M8.73M-13.00M-346.00K
76.46M198.00K244.73M112.59M75.68M
-1.26M-2.07M-2.78M-1.49M-346.00K
-18.28M-88.48M126.01M18.59M41.02M